Dermisonics Total Assets from 2010 to 2025
Dermisonics' Total Assets are increasing with slightly volatile movements from year to year. Total Assets are predicted to flatten to about 16.4 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.
Total Assets | First Reported 2010-12-31 | Previous Quarter 23.1 M | Current Value 16.4 M | Quarterly Volatility 5.2 M |
Check Dermisonics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermisonics' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 3.8 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.04. Dermisonics financial statements analysis is a perfect complement when working with Dermisonics Valuation or Volatility modules.
Dermisonics | Total Assets | Build AI portfolio with Dermisonics Stock |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Dermisonics Correlation against competitors. For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Medical Devices space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dermisonics. If investors know Dermisonics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dermisonics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dermisonics is measured differently than its book value, which is the value of Dermisonics that is recorded on the company's balance sheet. Investors also form their own opinion of Dermisonics' value that differs from its market value or its book value, called intrinsic value, which is Dermisonics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dermisonics' market value can be influenced by many factors that don't directly affect Dermisonics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dermisonics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermisonics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermisonics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.